CSPC Ouyi Pharmaceutical

CSPC Ouyi Pharmaceutical is a core subsidiary of the CSPC Pharmaceutical Group, one of China's leading pharmaceutical conglomerates. The company specializes in the research, development, and large-scale production of finished drug products across several therapeutic areas, including cardiovascular disease, anti-infectives, and neurology. It operates significant manufacturing facilities that meet international GMP standards, exporting products to global markets including the United States and the European Union. Key products in its portfolio include NBP for ischemic stroke and Xuanning for hypertension, both of which are market leaders in China. As a vital part of the CSPC ecosystem, Ouyi integrates advanced chemical synthesis and formulation technologies with the group's broader R&D initiatives. The company is recognized for its high-quality generic medicines and its increasing focus on innovative drug delivery systems.